LANCET, vol.365, no.9454, pp.123-129, 2005 (SCI-Expanded)
Background Treatment of HBeAg-positive patients with chronic hepatitis B is not effective in most. A combination of immunomodulatory pegylated interferon alfa-2b and antiviral lamivudine might improve the rate of sustained response.